Purchase Order 75N95023P00486
Award Date 9/1/23
Potential Completion Date 8/31/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse (NIDA) awarded a $24,877.54 firm fixed-price purchase order to EMD Millipore Corp (doing business as Milliporesigma) on December 17, 2025, for the procurement of a Milli-Q IQ 7003 water purification system. The system is required by the Harvey Lab to support water purification needs for cell culture experiments conducted at the place of performance in Baltimore, Maryland. This contract represents a competitive procurement with no set-aside designation and...
- This federal contract award is a purchase order from the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to EMD Millipore Corp, a foreign-owned, for-profit manufacturer of laboratory products and services. The contract, valued at $17,795.38, is a firm-fixed-price modification to de-obligate funds and has an ultimate completion date of September 13, 2021. The award does not utilize any set-aside designations. EMD Millipore Corp,...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $12,087 purchase order to Med Associates, Inc., doing business as Med Associates, for unspecified services or products. The contract has a one-year period of performance beginning July 7, 2023 through July 6, 2024 and utilizes a firm fixed price contracting structure. Place of performance will be Med Associates' Baltimore, Maryland location. No additional details were...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order valued at $117,877.68 to EMD Millipore Corp (doing business as Milliporesigma) for maintenance services on six Milli-Q Advantage A10 water purification systems. This contract, awarded on June 30, 2020, with completion scheduled for June 30, 2025, represents Option Year 4 under the FY26 Underutilized Domestic Options (UDO) Initiative pursuant to Executive Order 14042. The work will be...
- The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,877.54 firm fixed-price purchase order to Sigma-Aldrich, Inc., a large, foreign-owned, for-profit life science and high technology company. The award is to provide a Milli-Q IQ 7003 water purification system needed for cell culture experiments. This purchase order does not utilize a small business set-aside. Sigma-Aldrich holds two significant federal contract indefinite delivery vehicles (IDVs) - a $50 million...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $10,465 firm fixed price purchase order to Cambrex High Point, Inc. to support retesting of the GLWL-01 reference standard and project specific funding. Cambrex will perform the work in Baltimore, Maryland over a one year period from July 2023 through July 2024. The National Institute on Drug Abuse conducts important biomedical research on drug abuse and addiction to improve...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,825 purchase order to Sigma-Aldrich, Inc. for contract 1107546 under contract number 23-005532. Performance will take place in Baltimore, Maryland over the course of one year beginning in September 2023. The firm fixed price contract is for the procurement of products or services to support NIH/NIDA research efforts, though details of the work were not provided....
- EMD Millipore Corporation has been awarded a firm fixed-price purchase order valued at approximately $13,000 by the National Institutes of Health Clinical Center of the Department of Health and Human Services. Under this contract, EMD Millipore will provide unspecified products or services to the NIH Clinical Center in Burlington, Massachusetts over a one-year period of performance beginning in October 2023. As the prime contractor, EMD Millipore will be responsible for fulfilling the contract...
- EMD Millipore Corporation has been awarded an $11,284.88 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide a one-time service and required kits for water purification systems at the agency's location in Burlington, Massachusetts. As the prime contractor, EMD Millipore will deliver maintenance and consumables for filtration installations supporting the NIH's research...
- This $11,044.55 fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to EMD Millipore Corp, a foreign-owned manufacturer of laboratory equipment and consumables. The award is for the provision of a Millipore Milli-Q IQ 7000 water purification system, which is used extensively in biomedical research, drug development, and testing programs across government,...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $12,199.20 firm fixed price purchase order to EMD Millipore Corporation for MILLI-Q ADVANTAGE A10 water purification systems and associated equipment. EMD Millipore will deliver the systems and parts to support NIH research efforts in Baltimore, Maryland over a one year period of performance from September 2023 through August 2024. As the leading federal funder of substance abuse research, the award will assist NIDA's mission of advancing science on the causes and consequences of drug use and addiction and their treatment through an interdisciplinary research approach.
Generated 12/22/23, 10:07 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 7/28/23 |